[1]徐鸿燕李泓莹旷梦玲裴彤荣超.金砖五国卫生技术评估应用比较研究[J].中国卫生质量管理,2023,30(02):085-89.[doi:10.13912/j.cnki.chqm.2023.30.2.19 ]
　XU Hongyan,LI Hongying,KUANG Mengling.A Comparative Study on Application of Health Technology Assessment in BRICS[J].Chinese Health Quality Management,2023,30(02):085-89.[doi:10.13912/j.cnki.chqm.2023.30.2.19 ]
点击复制

金砖五国卫生技术评估应用比较研究
分享到：

《中国卫生质量管理》[ISSN:1006-7515/CN:CN 61-1283/R]

卷:
第30卷
期数:
2023年02期
页码:
085-89
栏目:
卫生技术评估专栏
出版日期:
2023-02-15

文章信息/Info

Title:
A Comparative Study on Application of Health Technology Assessment in BRICS
作者:
徐鸿燕李泓莹旷梦玲裴彤荣超
浙江中医药大学人文与管理学院
Author(s):
XU Hongyan; LI Hongying; KUANG Mengling
School of Humanities and Management, Zhejiang Chinese Medical University
关键词:
金砖国家; 卫生技术评估; 机构设置; 经济评估
Keywords:
BRICS;  Health Technology Assessment;  Institution Setting;  Assessment of Economy
分类号:
R197.323
DOI:
10.13912/j.cnki.chqm.2023.30.2.19
文献标志码:
A
摘要:
卫生技术评估（HTA）能够为医疗卫生服务提供可靠决策依据。结合文献及国内外卫生技术评估网站的相关资料，从HTA的机构设置、职责范围、资金来源、流程等方面，对金砖五国HTA情况进行梳理和比较分析发现，金砖五国HTA发展水平不一，各国处于HTA发展的不同阶段。其中，巴西和中国的HTA体系发展较为完善，南非发展较为缓慢。金砖五国的HTA发展面临着缺乏专业知识、医疗卫生体系不健全等挑战，需加快发展步伐；巴西、中国仍需进一步加大政府投入，完善HTA体系建设评估指南，提升HTA研究能力；印度应扩大HTA评估网络，提高评估流程的透明度和客观性；南非需加快建立HTA机构。
Abstract:
Health technology assessment (HTA) can provide reliable decision-making basis for healthcare services. Based on the literature and relevant data from domestic and foreign health technology assessment websites, the HTA situation in BRICS countries was sorted out and compared from the aspects of HTA institutional setup, responsibility scope, funding source, process, etc. It was found that the development level of HTA in BRICS countries was different and each country was at different stages of HTA development. Among them, the HTA system in Brazil and China had developed relatively well, while the HTA system in South Africa had developed relatively slowly. HTA development in BRICS countries faced with challenges such as a lack of expertise and unsound medical and health systems, which needed to be accelerated the pace of development. Brazil and China still needed to further increase government input, improve HTA system construction evaluation guidelines, and improve HTA research capacity. India should expand the HTA evaluation network and improve the transparency and objectivity of the evaluation process. South Africa needed to speed up the establishment of the HTA institution.

参考文献/References:

［1］夏 晴,熊季霞,姚育楠.国内医改前后卫生技术评估研究对比［J］.医学信息学杂志,2020,41(10):18-22. ［2］李 静,李幼平,刘 鸣.卫生技术评估与循证医学［J］.华西医学,2000，15(1):6-9. ［3］邓子如,王伟,郭敏璐,等.金砖国家卫生外交政策及其参与全球卫生治理的经验［J］.中国卫生政策研究,2020,13(8):50-57. ［4］OORTWIJN W, BROOS P, VONDELING H, et al. Mapping of health technology assessment in selected countries［J］. International Journal of Technology assessment in Health Care, 2013, 29(4): 424-434. ［5］PEREIRA VC, BARRETO JOM, NEVES FAR. Health technology reassessment in the Brazilian public health system: analysis of the current status［J］. Plos One, 2019, 14(7): e0220131. ［6］LIMA SGG, BRITO CD, ANDRADE CJCD. Health technology assessment in Brazil–an international perspective［J］. Ciência & Saúde Coletiva, 2019, 24(5): 1709-1722. ［7］KHABIBULLINA A, GERRY CJ. Valuing health states in Russia: a first feasibility study［J］. Value in Health Regional Issues, 2019, 19: 75-80. ［8］PRINJA S, DOWNEY LE, GAUBA VK, et al. Health technology assessment for policy making in India: current scenario and way forward［J］. Pharmaco Economics-Open, 2018, 2(1): 1-3. ［9］MACQUILKAN K, BAKER P, DOWNEY L, et al. Strengthening health technology assessment systems in the global south: a comparative analysis of the HTA journeys of China, India and South Africa［J］. Global Health Action, 2018, 11(1): 1527556. ［10］DANG A, DANG D, VALLISH BN. Importance of evidence-based health insurance reimbursement and health technology assessment for achieving universal health coverage and improved access to health in India［J］. Value in Health Regional Issues, 2021, 24: 24-30. ［11］傅 卫,赵 琨.中国卫生技术评估的发展与挑战［J］.卫生经济研究,2019,36(3):3-5. ［12］王海银,何 达,王贤吉,等.国内外卫生技术评估应用进展及建议［J］.中国卫生政策研究,2014,7(8):19-23. ［13］赵 锐,赵 琨.卫生技术评估走好中国特色发展之路［J］.中国卫生,2019,10(29):76-78. ［14］Wilkinson M, Gray AL, Wiseman R, et al. Health technology assessment in support of national health insurance in South Africa［J］. International Journal of Technology Assessment in Health Care, 2022,38(1):e44. ［15］MUELLER D. Addressing the challenges of implementing a Health Technology Assessment policy framework in South Africa［J］.International Journal of Technology Assessment in Health Care, 2020,36(4):453-458. ［16］王海银, 孙 辉, 王昊德,等. 价值重塑下的我国卫生技术评估发展与展望［J］. 中国卫生质量管理, 2022,29(6):1-3,8. ［17］房 良,王海银.国外卫生技术评估现状及筹资模式对我国的启示［J］.卫生软科学,2021,35(8):55-58. ［18］MCGEE S, TRUTER I, BRAND M, et al. The South African guidelines for pharmacoeconomic submissions: a review in context of existing legislation and challenges to implementation［J］.Value in Health,2015,18:A573.

相似文献/References:

[1]唐檬,陈英耀,茅艺伟,等.中国卫生技术评估决策转化现状及影响因素的定性研究[J].中国卫生质量管理,2015,22(06):095.
[2]王海银 张晓溪 房良 金春林.我国卫生技术评估流程规范研究[J].中国卫生质量管理,2016,23(06):060.[doi:10.13912/j.cnki.chqm.2016.23.6.21]
[3]魏巍 张涛 鱼敏.便携式早期清创冲洗器的卫生技术评估[J].中国卫生质量管理,2018,25(03):079.[doi:10.13912/j.cnki.chqm.2018.25.3.24]
[4]张曙欣 陈校云 冯力 宋杨杨 胡可慧 黄婉茹 裴治纲.澳大利亚和新西兰新兴卫生技术水平扫描网络的实践与启示[J].中国卫生质量管理,2019,26(02):106.[doi:10.13912/j.cnki.chqm.2019.26.2.31]
[5]孙辉 金春林 程文迪 房良 王海银.西班牙卫生技术评估的发展应用及启示[J].中国卫生质量管理,2019,26(03):106.[doi:10.13912/j.cnki.chqm.2019.26.3.29]
[6]王海银 丛郦萱 彭颖 王美凤 金春林.我国新医疗技术的定价及支付优化策略探讨[J].中国卫生质量管理,2020,27(01):105.[doi:10.13912/j.cnki.chqm.2020.27.1.27]
[7]程文迪 孙辉 房良 王海银.泰国卫生技术评估机制建设现状及启示[J].中国卫生质量管理,2020,27(01):109.[doi:10.13912/j.cnki.chqm.2020.27.1.28]
[8]邱英鹏赵翔肖月赵羽西.高值医用耗材定义与治理内涵研究[J].中国卫生质量管理,2021,28(05):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01 ]
　QIU Yingpeng,ZHAO Xiang,XIAO Yue.The Definition and Governance Connotation of High Value Medical Consumables[J].Chinese Health Quality Management,2021,28(02):001.[doi:10.13912/j.cnki.chqm.2021.28.5.01 ]
[9]赵羽西邱英鹏肖月.英国高值医用耗材准入及招采管理经验分享：以英格兰为例[J].中国卫生质量管理,2021,28(05):008.[doi:10.13912/j.cnki.chqm.2021.28.5.03 ]
　ZHAO Yuxi,QIU Yingpeng,XIAO Yue.Access and Procurement Management of High Value Medical Consumables in the UK: A Case Study of England[J].Chinese Health Quality Management,2021,28(02):008.[doi:10.13912/j.cnki.chqm.2021.28.5.03 ]
[10]邱英鹏赵羽西赵翔肖月.澳大利亚假体类高值医用耗材医保准入管理经验及启示[J].中国卫生质量管理,2021,28(05):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]
　QIU Yingpeng,ZHAO Yuxi,ZHAO Xiang.Experience in Medical Insurance Access Management of Prosthetic High Value Medical Consumables in Australia and Its Implications[J].Chinese Health Quality Management,2021,28(02):012.[doi:10.13912/j.cnki.chqm.2021.28.5.04 ]

更新日期/Last Update: 2023-02-15